Accelerate Diagnostics completes IVD registration of the Accelerate Arc system with U.S. FDA

SHARE
May. 15, 2022

Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate.

Accelerate Arc system now available as a registered IVD

Today we announced the completed registration of the Accelerate Arc system as an IVD with the U.S. Food and Drug Administration and subsequent commercialization of the Accelerate Arc module and BC kit.

Explore the Accelerate Arc system ?

“On the heels of publishing robust data at the 32nd European Congress for Clinical Microbiology and Infectious Diseases demonstrating the value of using the automated Accelerate Arc Module and BC kit, we’re excited to announce this product is now registered as an IVD with the FDA, and will soon be available to healthcare facilities in the U.S. market,” said John Meduri, Chief Strategy Officer for Accelerate Diagnostics.

Simple load-and-go workflow

The simple load-and-go workflow eliminates the need for batching multiple specimen tests, cutting hours off the wait for microbial ID results for positive blood cultures. The Accelerate Arc Module requires just 2-3 minutes of hands-on time to run and is simple enough to be used on all shifts, by any laboratory technician, freeing up valuable technician time by automating the MALDI workflow.

The Accelerate Arc system has the potential to cut hours of wait time, eliminate laborious hands-on sample prep for microbial ID results and offer significant cost savings for healthcare facilities compared to current methods for positive blood cultures.

Contact supplier

Drop file here or browse